Treanda
NDC Package 63459-396-02

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Treanda is a medication used to treat certain types of cancer. Marketed by Cephalon, Llc, this product is identified by NDC 63459-396 and is authorized under FDA application NDA022249.

Identification & Billing

NDC Package Code
63459-396-02
Package Description
1 VIAL, SINGLE-DOSE in 1 CARTON / 2 mL in 1 VIAL, SINGLE-DOSE
Product Code
63459-396
11-Digit Billing Format
63459039602
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Treanda
Dosage Form
-
Usage Information
This medication is used to treat certain types of cancer. Bendamustine belongs to a class of cancer chemotherapy drugs known as alkylating agents. It works by killing cancer cells or slowing their growth.

Regulatory & Marketing

Labeler Name
Cephalon, Llc
FDA Application #
NDA022249
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
11-05-2014
End Marketing Date
05-31-2017
Listing Expiration
05-31-2017
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 63459-396-02 identifies a specific commercial package of 1 vial, single-dose in 1 carton / 2 ml in 1 vial, single-dose of Treanda, labeled by Cephalon, Llc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Cephalon, Llc on November 05, 2014. The current certification is valid through May 31, 2017.

What are the primary indications for this medication?

This medication is used to treat certain types of cancer. Bendamustine belongs to a class of cancer chemotherapy drugs known as alkylating agents. It works by killing cancer cells or slowing their growth.

How is this Cephalon, Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 63459039602. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
63459-396-02
11-Digit CMS (5-4-2)
63459-0396-02

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.